The multi-year collaboration includes the deployment of the AISight Dx platform and AI algorithms across the health system’s laboratory network.

PathAI and MedStar Health announced a multi-year strategic collaboration to deploy the AISight Dx Digital Pathology Platform and various AI algorithm products across the health system’s multi-site network.

AISight Dx is a cloud-native digital pathology image management system designed to support laboratory workflows, clinical operations, and research initiatives. The platform has received clearance from the Food and Drug Administration for primary diagnosis in the US. It combines slide management, viewing, and collaboration with AI integration to assist with laboratory efficiency and consistency.

MedStar Health will also deploy specific algorithms, including ArtifactDetect, a workflow tool, and TumorDetect, which is currently for research use only. The implementation will support a network of laboratories and more than 40 pathologists.

“At MedStar Health, we are focused on scaling high-quality care across a large and growing health system, including a rapidly expanding outreach business, and digital pathology is a critical enabler of that mission,” says Moira Larsen, MD, physician executive director of MedStar Medical Group Pathology at MedStar Health, in a release. “By deploying AISight Dx and advanced AI applications, we are modernizing our pathology infrastructure in a way that makes us more connected, more efficient, and better positioned to bring innovative diagnostics into everyday practice.”

The deployment follows MedStar Health’s participation in PathAI’s Early Access Program and previous research initiatives, such as an independent validation of the AIM-HER2 Breast algorithm. The collaboration establishes a foundation for further work within the Precision Pathology Network, including joint research, the generation of real-world multimodal data, support for clinical trials, and the development of AI diagnostics.

“Digital pathology and AI are transforming how health systems generate insight and scale impact,” says Nick Brown, chief growth officer of PathAI, in a release. “Through our collaboration with MedStar Health, we’re building a modern digital infrastructure that will accelerate innovation and future-proof MedStar’s pathology growth.”

ID 184936728 © Jhvephotos | Dreamstime.com

Related Reading: